Agouron Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGOURON, and what generic and branded alternatives to AGOURON drugs are available?
AGOURON has three approved drugs.
Drugs and US Patents for Agouron
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Agouron
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | 5,484,926*PED | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | 6,162,812*PED | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | 6,162,812*PED | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | 5,952,343*PED | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | 5,952,343*PED | ⤷ Try a Trial |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | 5,952,343*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.